Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in ABBV — AbbVie Inc.

CIK 1214717 BOSTON, MA

Position in ABBV

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$10,164,956,491
-$32,547,638 QoQ
Shares Held
46,737,581
+4.7% QoQ
Ownership
2.65%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.92614080733019.ToString("F0")% Shared 0.ToString("F0")% None 0.0738591926698132.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $67,874,952,284 across 14 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ABBV
AbbVie Inc.
This page
46,737,581 $10,164,956,491

All Filings in ABBV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $10,164,956,491 46,737,581
2025-12-31 $10,197,504,129 44,629,980
2025-09-30 $9,363,360,208 40,439,493
2025-06-30 $7,272,285,512 39,178,351
2025-03-31 $8,014,892,176 38,253,590
2024-12-31 $6,600,654,593 37,144,933
2024-09-30 $7,141,083,166 36,161,045
2024-06-30 $6,291,653,759 36,681,750
2024-03-31 $6,827,776,311 37,494,653
2023-12-31 $5,736,599,805 37,017,486
2023-09-30 $5,397,041,058 36,207,172
2023-06-30 $4,709,209,336 34,952,938
2023-03-31 $5,425,754,996 34,045,021
2022-12-31 $5,454,742,979 33,752,509
2022-09-30 $4,540,391,539 33,830,501
2022-06-30 $4,607,271,359 30,081,427
2022-03-31 $4,655,839,889 28,720,251
2021-12-31 $3,861,465,288 28,518,946
2021-09-30 $2,994,535,059 27,760,592
2021-06-30 $3,068,871,055 27,244,949
2021-03-31 $2,947,111,863 27,232,599
2020-12-31 $2,858,968,049 26,681,923
2020-09-30 $2,289,170,956 26,135,072
2020-06-30 $2,843,154,562 28,958,592
2020-03-31 $1,963,683,345 25,773,505